Erlotinib eradicates brain metastases from epidermal growth factor receptor mutant non-small cell lung cancer

Erlotinib eradicates brain metastases from epidermal growth factor receptor mutant non-small cell lung cancer

Erlotinib is active in patients with lung cancer; especially those who demonstrate a mutation in exons 18-21 in the epidermal growth factor receptor (EGFR) gene. Patients with lung cancer and brain metastases have poor prognosis as systemic chemotherapy is ineffective in treating the central nervous...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Siavash Jabbari, Michael Pins, Kimberly Kruczek, Chadi Nabhan
Formato: article
Lenguaje:EN
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2011
Materias:
brain metastasis
erlotinib
lung cancer
tarceva
Medicine
R
Acceso en línea:https://doaj.org/article/fc728a39eb094ea3938b165e4526d5b2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares